Sign in
TerminatedNo phase

PACESETTER: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor

Key facts

Who runs it
Northern California Institute of Research and Education
Where
Charleston, Columbia, Orangeburg, and San Francisco, United StatesSee the 4 sites
Trial code
Status
Terminated
People taking part
120 people enrolled
Started
14 Jul 2020
Ended
28 Feb 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • PACESETTER
Record updated
11 December 2025
Why it stopped
Study delays and ran out of funding

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • African American or non-Hispanic white
  • history of stroke (within six months of symptom onset)
  • uncontrolled HTN (SBP ≥ 130 mmHg at the last clinical encounter post-stroke prior to recruitment)
  • owning a smartphone with a data plan
  • able to take their own BP and self-administer medications

Who cannot take part

  • Any condition that would limit participation in follow up assessments including severe cognitive impairment/dementia; severe global disability (modified Rankin Score ≥ 3); BMI> 40kg/m\^2; Not being able to speak, hear, or understand English

Where in United States

  • Medical University of South CarolinaCharleston, United States
  • University of South CarolinaColumbia, United States
  • Regional Medical Center: Orangeburg HospitalOrangeburg, United States
  • NCIRESan Francisco, United States

About the trial

What the trial wants to find out

Program to Avoid Cerebrovascular Events through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor (PACESETTER) aims to assess the incorporation of its stroke intervention into 2 safety net/academic health systems in a given US state especially burdened by stroke, thereby enhancing knowledge about the complexity of stroke interventions, and especially the nature of the challenges encountered in low resource settings and for populations traditionally underrepresented in research. Altogether, the intervention, if proven implementable and effective, may eventually be exported to other medically underserved populations in the US beyond SC as a feasible model of post-stroke management.

The 2 groups in the trial

  • PACESETTERTreatment being tested

    Participants in the PACESETTER arm received a multicomponent, mHealth-enabled self-management program designed to improve post-stroke blood-pressure control. Each participant was provided a Bluetooth-enabled UA-767Plus BT home blood-pressure monitor, a Vaica electronic medication tray that emitted visual and auditory reminders, and the PACESETTER smartphone app. The app delivered instructional videos, enabled automatic transmission of BP and adherence data to a secure server, and generated tailored SMS messages based on self-determination-theory constructs of competence and autonomous regulation. Participants also received twice-weekly educational text messages regarding hypertension and stroke prevention, medication adherence, and communication with clinicians. Bi-weekly adherence and BP summaries were sent to study physicians to guide medication adjustments. Study coordinators contacted participants monthly to ensure device functioning and collect follow-up data.

  • Healthy Lifestyle Intervention GroupNo study treatment, for comparison

    General lifestyle SMS matched in frequency and length to the intervention; monthly follow-ups; no devices, adherence monitoring, or physician-directed feedback.

Results explained

A paper that names this trial, explained in plain words.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor
Publications
Record updated
11 December 2025